News

Ophthalmology Pioneer Humayun on Second Sight’s "Moonshot" and What Tech Is Next in Retina - Eye On Innovation Article - OIS - Healthegy

Ophthalmology Pioneer Humayun on Second Sight’s “Moonshot” & What Tech is Next in Retina

By Tom Salemi | July 6, 2016

Next month, Mark Humayun, MD, who teamed with Eugene De Jean, MD, to perform the experimental surgery that brought flashes of light to a patient…

Eye on Five – June Edition

By Rich Kirkner | July 1, 2016

After Trial Fails, Acucela Goes It Alone with Emixustat Otsuka Pharmaceutical Group terminated its agreement with Acucela to develop emixustat after the Phase IIB/III trial…

Can Ocular Therapies Diversify Biogen Portfolio?

By Michelle Dalton | June 29, 2016

Biotechnology company Biogen (Cambridge, MA) recently committed $20 million into a collaboration with the University of Pennsylvania to co-develop gene therapies using next-generation adeno-associated virus…

What’s Next for Acucela? Wait and See - Eye On Innovation Article - OIS - Healthegy

What’s Next for Acucela? Wait & See

By Rich Kirkner | June 22, 2016

Now that Acucela and Otsuka Pharmaceutical of Japan have torn up their collaborative deal to develop emixustat, which failed to meet its primary endpoint in…

Stem Cell Therapies for AMD Making Strides

By Michael Smolinsky | June 15, 2016

In 2013, the first clinical study of stem cells in ophthalmology set high hopes that companies may one day develop cell-based therapies for neovascular age-related…

Jonhson & Johnson’s Plans for Smart and 3D Printable Contact Lenses - Eye On Innovation Article - Helathegy

J&J’s Plans for Smart & 3D Printable Contact Lenses

By Rich Kirkner | June 8, 2016

Personalized contact lenses that can relieve eye allergies, reduce glare and eyestrain, and treat presbyopia are all concepts moving through the pipeline at Johnson &…

Eye on Five – May Edition

By Tom Salemi | June 3, 2016

Burden of Eye Problems to Double By 2050 Researchers at the University of Southern California (USC) Roski Eye Institute reported in JAMA Ophthalmology that the…

Omeros Sees the Corner and Is Ready to Turn - Eye On Innovation Article - Healthegy

Omeros Sees the Corner & is Ready to Turn

By Rich Kirkner | May 31, 2016

A year out from getting US approval of its Omidria agent for cataract surgery, Omeros has bulked up its sales force in anticipation of a…

Three Top Stories from OIS@ASCRS Reporters’ Notebook

By Tom Salemi | May 24, 2016

Each day, we’re adding videos, reports and interviews from OIS@ASCRS to OIS.NET. We asked our team of writers to share their personal favorites from the…

Why Consolidation Has Not Tamped Down Innovation

By Rich Kirkner | May 18, 2016

Despite what some see as consolidation among drug and device companies in ophthalmology, a number of factors continue to drive innovation – from unmet needs…

OIS@ASCRS Brings Innovators Together in New Orleans

By Tom Salemi | May 13, 2016

More than 500 leaders in ophthalmology gathered last week at the InterContinental Hotel in New Orleans to discuss new technologies used to treat the anterior…

Mixing MIGS and Meds - Eye On Innovation Article

Mixing MIGS & Meds

By Michelle Dalton | May 3, 2016

Long gone are the days where glaucoma surgery meant an invasive procedure with the likelihood of a serious complication developing down the road – while…

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.